later. She described a post void sensation of "sand in my bladder." No systemic 23 symptoms occurred in the interval. Exam showed improved but residual erythema and 24
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on November 5, 2017 by guest http://jcm.asm.org/ Downloaded from mild edema of the labia minora and introitus. The vaginal epithelium was intact with 1 mild erythema suggesting atrophy. A straight catheter urine sample was obtained and 2 patient was given another course of ciprofloxacin for 10 days. Urine microscopy showed 3 significant pyuria with white blood cell clumps and many bacteria and culture again 4 yielded >50,000 CFU/ml of Lactobacillus spp which was again considered to be a 5 contaminant. 6
After no improvement following the third course of ciprofloxacin treatment, an 7 infectious disease consult was obtained. Urine studies were repeated. Again, urine 8 microscopy showed significant pyuria, WBC clumping, and many bacteria and culture 9 grew >50,000 CFU/ml of Lactobacillus species. E-test minimum inhibitory 10 concentrations (MICs) determined on Mueller-Hinton agar incubated anaerobically were: 11 doxycycline, 0.5 ug/ml; ampicillin, 0.25; erythromycin, ≤0.03; vancomycin, 0.5; 12 linezolid, 1; moxifloxacin, 1; and ciprofloxacin, >32. Bacterial 16S rRNA gene 13 sequencing was performed by our institution's Molecular Pathology Laboratory using the 14 MicroSeq 500 16S rDNA Bacterial Identification Sequencing Kit and a 3130 Genetic 15 Analyzer (Applied Biosystems; Foster City, CA) according to the manufacturer's 16 instructions. The sequence data obtained was then compared with known 16S rRNA 17 gene sequences in the GenBank database by BLAST search. Greater than 99.0% identity 18 between the isolate and database sequence was required for identification at both the 19 genus and species level (with greater than 0.8% separation between different species) (2). 20
Analysis of the isolate's 16S rRNA gene sequence revealed it to be Lactobacillus 21
delbrueckii. 22
Based on susceptibility test results and documented allergies, the patient was 23 prescribed a 2 week course of clarithromycin therapy, 250mg BID, with resolution of her 24
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on November 5, 2017 by guest http://jcm.asm.org/ Downloaded from urgency and dysuria and marked improvement of her urinary frequency. Urine studies 1 following the end of therapy showed a significant reduction in the number of urine WBCs 2 (see Table 1 ). A leukocyte esterase test was negative as was a straight catheter urine 3 culture. 4
A retroperitoneal ultrasound showed mild cortical thinning of the kidneys 5 secondary to prior reflux, chronic infection or medical renal disease. There was no 6 evidence of hydronephrosis or stones. There was a partially exophytic, isoechoic mass at 7 the junction of the mid and inferior pole of the left kidney measuring approximately 3.4 x 8 2.6 x 3.7 cm, which partially indented into the renal sinus. Subsequent abdominopelvic 9 magnetic resonance imaging studies revealed multiple peripelvic simple cysts in the 10 bilateral kidneys without solid or enhancing lesions, several areas of cortical thinning in 11 The evidence for L. dulbrueckii being the cause of urinary tract infection in the 3 patient described herein is convincing. As seen in Table 1 , Lactobacillus spp was 4 recovered repeatedly in significant quantities, usually in pure culture, from both mid-5 stream voided and straight catheter urine specimens from our patient over a six-month 6 period of time during which she remained nearly constantly symptomatic. Significant 7 pyuria also persisted over this time. On three occasions during this interval, she received 8 a course of therapy with ciprofloxacin and failed therapy. Her isolate of L. dulbrueckii 9 was found to be high level resistant to ciprofloxacin. When finally treated with 10 clarithromycin, an antimicrobial agent to which her isolate was susceptible, she promptly 11 responded to therapy. Follow-up urine cultures were negative and her pyuria cleared. 12
During the 2 months since resolution of her symptoms, her infection has not recurred. In 13 addition, numerous urine nitrite tests performed during the period our patient was 14 symptomatic, were all negative despite persistent pyuria. Lactobacillus spp does not 15 reduce nitrate. Finally, while symptomatic, several urine specimens from our patient 16 were found to be markedly acidic (pH = 5.0). Lactobacillus spp is an acid producing 17 bacteria. 18 We are confident that the extensive culture work-up of our patient excluded other 19 typical bacterial uropathogens as a cause of her disease. We cannot completely exclude 20 organisms such as Mycoplasma hominis or Ureaplasma urealyticum as being responsible 21 for her symptoms, however, infection due to either of these organisms would have been 22 expected to have responded to ciprofloxacin treatment. As noted above, our patient 23 The pathogenesis of infection in our patient is obscure. One intriguing possibility 3 was that our patient acquired her infecting strain of L. dulbrueckii through prior use of 4 probiotic preparations, however, she denied any past history of probiotic administration. 5
Lactobacillus delbrueckii, is commonly used in the preparation of numerous dairy food 6 products, primarily yogurts and cheeses (8, 9). A second possibility is that our patient 7 first developed vaginal colonization with L. delbrueckii as a consequence of acquiring 8 this organism from ingested foods. She then went on to develop persistent infection with 9 this relatively avirulent bacterium as a consequence of all of the antecedent pathology 10 present in her genitourinary tract which could predispose to urinary tract infection. 

